Mutations in the XPC gene in families with xeroderma pigmentosum and consequences at the cell, protein, and transcript levels.
Xeroderma pigmentosum (XP)-C is one of the more common complementation groups of XP, but causative mutations have thus far been reported for only six cases (S. G. Khan et al., J. Investig. Dermatol., 115: 791-796, 1998; L. Li et al., Nat. Genet., 5: 413-417, 1993). We have now extended this analysis by investigating the genomic and coding sequence of the XPC gene, the level of expression of the XPC transcript and the status of the XPC protein in 12 unrelated patients, including all of the 8 Italian XP-C cases identified thus far and in 13 of their parents. Eighteen mutations were detected in the open reading frame of the XPC gene, 13 of which are relevant for the pathological phenotype. The mutations are distributed across the gene, with no indication of any hotspots or founder effects. Only 1 of the 13 relevant changes is a missense mutation, the remainder causing protein truncations as a result of nonsense mutations (3), frameshifts (6), deletion (1) or splicing abnormalities (2). These findings indicate that the XPC gene is not essential for cell proliferation and viability and that mutations causing minor structural alterations may not give an XP phenotype and may not, therefore, be identified clinically. XP13PV was the only patient carrying a missense mutation (Trp690Ser on the paternal allele). This was also the only patient in which the XPC transcript was present at a normal level and the XPC protein was detectable, although at a lower than normal level. No quantitative alterations in the transcript or protein levels were detected in the XP-C heterozygous parents. However, the expression of the normal allele predominated in all of them, except the father of XP13PV, which suggests the existence of a possible mechanism for monitoring the amount of the XPC protein.
Chavanne
F
F
Istituto di Genetica Biochimica ed Evoluzionistica CNR, Pavia, Italy.
Broughton
B C
BC
Pietra
D
D
Nardo
T
T
Browitt
A
A
Lehmann
A R
AR
Stefanini
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D019943:Amino Acid Substitution; D002478:Cells, Cultured; D002648:Child; D002675:Child, Preschool; D004260:DNA Repair; D004268:DNA-Binding Proteins / Q000235:genetics*; D005260:Female; D005347:Fibroblasts / Q000166:cytology / Q000473:pathology / Q000528:radiation effects; D005786:Gene Expression Regulation; D006801:Humans; D007558:Italy; D008297:Male; D009154:Mutation; D009679:Nuclear Family; D016366:Open Reading Frames; D017354:Point Mutation; D011110:Polymorphism, Genetic; D017384:Sequence Deletion; D012867:Skin / Q000166:cytology / Q000473:pathology / Q000528:radiation effects; D014158:Transcription, Genetic; D014466:Ultraviolet Rays; D014983:Xeroderma Pigmentosum / Q000235:genetics* / Q000473:pathology
D004268:DNA-Binding Proteins; C086984:XPC protein, human